cell therapy

Floodgate floodgates

Pharma

Cellares' recent wins have opened the floodgates for the IDMO

After speedrunning a series of major manufacturing milestones in the past year-and-a-half, the “biotech floodgates” have opened for Cellares.

Fraiser Kansteiner Jul 14, 2026 10:26am

cell therapy oncology cancer CAR-T cells

Cellares, Ori dominate automated cell therapy production: report

Jun 18, 2026 10:10am

Trust in block letters

Bayer diagnoses how to build trust in cell and gene therapies

May 6, 2026 10:45am

Kite

With ‘lessons learned,’ Kite preps for key CAR-T launch

Apr 28, 2026 11:30am

JNJ

J&J drafts designs for $1B cell therapy plant in Pennsylvania

Feb 18, 2026 11:23am

Charles River Boston Massachusetts

Fierce Biotech

Charles River to close Maryland CDMO site, lay off 20 staffers

Feb 3, 2026 12:20pm